Sonnet BioTherapeutics Holdings, Inc. Soared
Wed, Jul 02, 2025 at 07:18 PM
Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) rocketted at $4.15, representing a gain of 243%. On Wed, Jul 02, 2025, SONN:NASDAQ hit a New 2-Week High of $4.15. The stock got featured on our News Catalysts scanner on Sat, Jun 28, 2025 at 12:55 AM in the 'PRIVATE PLACEMENT' category. From Wed, Jun 18, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days
About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)
Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 3599.99%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 242.98%
- Mogo Inc. (MOGO:NASDAQ), 112.4%
- Blue Gold Limited (BGL:NASDAQ), 84.85%
- CID HoldCo Inc. (DAIC:NASDAQ), 77.66%
- Earlyworks Co., Ltd (ELWS:NASDAQ), 66.84%
- Namib Minerals (NAMM:NASDAQ), 59.53%
- NeOnc Technologies Holdings, Inc. (NTHI:NASDAQ), 55.59%
- Concorde International Group Ltd. (CIGL:NASDAQ), 50.93%
- Eyenovia, Inc. (EYEN:NASDAQ), 49.81%